We developed a clustered regularly interspaced short palindromic repeats (CRISPR)/retron system for multiplexed generation of substitution mutations by co-utilization of a retron system that continuously expresses donor DNA and a CRISPR/Cas9 cassette that induces cleavage at target genomic loci. Our system efficiently introduces substitution mutation in the Escherichia coli genome in a high-throughput manner. These substitution mutations can be tracked by analysis of retron plasmid sequences without laborious amplification of individual edited loci. We demonstrated that our CRISPR/retron system can introduce thousands of mutations in a single experiment and be used for screening phenotypes related to chemical responses or fitness changes. We expect that our system could facilitate genome-scale substitution screenings.
INTRODUCTION
Several genome-wide pooled screening methods have been recently developed 1-3 using the CRISPR/CRISPR-associated protein-9 (Cas9) system 4-6 for targeted gene knock-out, repression 1 , or activation 2 . These screening technologies utilize Cas9 and single-guide RNA (sgRNA) libraries constructed as lentiviral delivery systems that are integrated into the genome. Genome-integrated sgRNA sequences are then analyzed using next-generation sequencing (NGS) technologies to track the mutations introduced across genomic loci. The experimental procedures used in these approaches are convenient, enabling the analysis of selected mutants using algorithms 7, 8 . As such, these technologies have been used in a number of recent studies 1, 2, 9 .
The development of pooled screening technologies for substitution mutations has not advanced as rapidly as knock-out and transcriptional regulation methods. The development of pooled screening technologies is complicated by the requirement for an additional component, an independent donor DNA fragment that serves as a template for homology-directed repair and must be delivered with the corresponding sgRNA. To overcome this challenge, a recently developed Cas9 retron precise parallel editing via homology (CRISPEY) 10 method uses the retron system 11, 12 for donor DNA expression instead of separate transfection of donor DNA fragments. The retron system for Escherichia coli 13, 14 , comprising msr, msd, and a reverse transcriptase (RT), was modified to express single-stranded donor DNAs in yeast, and the modified retron was flanked by sgRNA. CRISPEY thus enables the preparation of both sgRNA and donor DNA using a single vector. The vector was also designed to insert a donor DNA-sgRNA pair for each target, which were prepared from commercially available oligo pools. The CRISPEY system enables high-throughput editing in which the efficiency is enhanced by the killing of unmodified cells. In addition, the abundance of each mutant can be monitored by sequencing of the vector amplified using common primers. However, although E. coli is the most widely used model organism 15, 16 in research related to metabolic engineering, molecular biology, and therapeutics, the CRISPEY system has not been extended to editing of the E. coli genome.
For editing the E. coli genome, lambda red recombination-based methods 17 such as multiplex automated genome engineering (MAGE) 18 have been used to generate genomic substitutions using only a library of oligonucleotides. However, tracking genomic mutations introduced using MAGE becomes more difficult as the number of engineered target loci increases, because target loci must be analyzed individually via laborious amplification 19 and subsequent sequencing.
In contrast to the above-mentioned approaches, the trackable multiplex recombineering method 20 enables tracking of variants via microarray-based capture. However, this method is not appropriate for introducing substitution mutations in coding regions because a tag sequence must be inserted into the targeted region. As such, methods that enable trackable, scarless introduction of substitution mutations in E. coli are needed. To fill this demand, we developed a method combining the retron and CRISPR systems and demonstrated genome engineering and screening in E. coli 6, 21 (Figure 1a) .
Our system enables highly efficient genome editing, and the abundance of each mutant is correlated with the retron portion of the plasmid; thus, mutations across the genome can be tracked using singleamplification reactions with common primers (Figure 1b) . Finally, we demonstrated that our system is suitable for genome-scale experiments involving E. coli.
RESULTS and DISCUSSION
First, we designed a programmable plasmid (pRC_blank_01) containing a sgRNA-expressing region and retron-encoding region, with the latter composed of the msd, msr, and RT (Supplementary Figure S1a, Tables S1 and S2). We then induced a single amino acid substitution to revert a premature stop codon (I239*) in the galactokinase enzyme (encoded by galK) in ENC (E. coli EcHB3 bearing plasmids encoding T7 polymerase and Cas9) (Figure 2a) . The 75-bp msd and sgRNA regions were cloned into pRC_blank_01 to generate pRC_galK_on. We then transformed pRC_galK_on into ENC cells via electroporation (Figure 2b , Supplementary Table S3 ).
Transformants were cultured in medium supplemented with isopropyl β -D-1-thiogalactopyranoside (IPTG) and inoculated into fresh medium every 12 h for 15 dilution cycles. The recombination efficiency was determined at six time points (cycles 0, 3, 6, 9, 12, and 15) via NGS; we obtained a recombination efficiency of 5.7% with 15 cycles of dilution (n=3). Moreover, the engineering efficiency increased as the dilution cycles progressed, whereas deactivated retrons (dead RT) did not promote such efficiency (n=2) (Figure 2c ).
Next, we tested various derivatives of pRC_galK_on ( Supplementary Table S2 ) to optimize the system parameters. First, we varied the conditions that affect the efficiency of homologous recombination. The effects of changing the length of msd (from 55 to 115 bp) 18, 22 and the presence/absence of Beta recombinase 13, 14 (which stabilizes ssDNA) were tested; optimal efficiency was obtained with an msd length of 95 bp and co-expression of Beta recombinase (Figure 2d, e ). We then examined the effect of varying conditions related to selection pressure using the CRISPR/Cas9 system. We changed the activity of the sgRNA by altering the 5' sequence 23 and the number of mismatches 5 that are known to affect CRISPR/Cas9 efficiency. The sgRNA in our system is designed to have extra guanines (GGG + 20 nt) in the 5' sequence due to the characteristics of the T7 promoter.
We tested "Gg18" 23 , which uses a shortened T7 transcription start site "GG" as first two bases in the 20-nt spacer sequence (GG + 18 nt) to remove the 5' extra bases. We also tested the effect of mismatches in the sgRNA sequence to modulate the efficiency of CRISPR/Cas9 5 . One mismatch in the middle of GGG + 20 nt formed a sequence with moderate sgRNA activity and enhanced editing efficiency (Figure 2f ). Standard and Gg18 sgRNAs appeared to kill the cells before editing due to high CRISPR/Cas9 efficiency, and sgRNAs with mismatches introduced into the left or right side did not effectively kill unedited cells. Thus, editing efficiency was enhanced with a 95-bp msd, coexpression of Beta recombinase, and use of a sgRNA with a mismatch in the middle. To exploit these optimized conditions, we constructed an improved programmable plasmid by introducing the Beta recombinase gene into pRC_blank_01 (pRC_blank_02) (Supplementary Figure S1b) .
The scalability of the CRISPR/retron system was assessed using degenerate bases. We also investigated whether the plasmid msd frequency is representative of the corresponding genomic mutant allele frequency. A msd oligomer containing six consecutive degenerate bases (N6) was synthesized to produce mismatch changes in the galK gene, and the oligomer was cloned into the plasmid with the galK-targeting sgRNA (Figure 3a) . We observed a recombination efficiency of 6.57%
with 15 cycles of dilution (n=2) (Supplementary Figure S3a) . The genomic engineering efficiency also increased with additional dilution cycles. On average, the engineered cell populations contained 1,651 genomic variant sequences after 15 cycles of dilution (n=2) of the 4,095 msds identified from the plasmid pool before transformation (Supplementary Figure S2) . Importantly, a strong positive correlation was observed at 15 cycles of dilution between msd (from a plasmid) and the genomic variant ratio based upon a comparison of normalized depth (ND) values (Figure 3b ) (Pearson's ρ =0.87, 0.84 for each replicate). In addition, the strength of the correlation increased with additional dilution cycles, as did clonal bias (Supplementary Figure S3b and c) . We presume that the clonal bias was associated with differences in survival rate between mutants. Because the editing efficiency is dependent on the number of mismatches 18 , unedited cells containing low-efficiency donor DNA are more likely to be eliminated via selection. For further validation, we analyzed the genomes and msd regions of individual colonies picked from each pool using Sanger sequencing, and this analysis exhibited similar trends ( Supplementary Table S4 ). Collectively, these results indicate that the variant ratio can be determined by tracking plasmid-borne msd sequences.
Next, we conducted a model study to evaluate the CRISPR/retron system for multiplex engineering.
We introduced substitution mutations in six non-essential genes (apt, cadA, kefB, malK, rpoB, and tolC [Supplementary Figure S4a) . The msd ratio for the plasmid of each variant was highly correlated with the genomic variant ratio at 15 cycles of dilution (Supplementary Figure S4b ) (ρ=0.96, n=3), and the recombination rate was high (46.8%) (Supplementary Figure S4c) . These results demonstrate that the CRISPR/retron system is suitable for use in generating and tracking substitution mutations at multiple loci.
We also investigated whether the CRISPR/retron system could be used to screen for chemicalresistant mutants (Figure 4a) , targeting seven genes (apt, cadA, cat, galK, kefB, malK, and rpoB [ Supplementary Table S5 ]); the cat product detoxifies the antibiotic chloramphenicol (cam). We designed the cat-targeted msd to revert the stop codon in the EcHB3 strain (see Methods, Supplementary Tables S3 and S6) ; therefore, only cells carrying the cat-reverting mutation could survive. Indeed, the results of NGS analysis of genomic DNA and the msd region showed that only cat-reverting mutants were enriched, based upon comparisons of the ND of cam-treated versus untreated control cells among the seven mutants (Figure 4b-d , Supplementary Tables S7-9 ). The enrichment was also confirmed by Sanger sequencing ( Supplementary Table S10 ). These results demonstrated that our CRISPR/retron system can be used to identify chemical-resistant mutants.
Finally, we extended the size of the library to a genome-wide scale to facilitate screening thousands of mutations across the genome. The library was designed to enable gene knock-out by introducing a stop codon in 3,222 genes in the E. coli genome. msd and sgRNA sequences were synthesized via high-throughput oligo synthesis and inserted into vectors for transformation of E. coli cells (Methods, Table S11 ) using 20 biological replicates. After 15 cycles of culture, ygbT was consistently enriched in a majority of the replicates. An ordinary least square model revealed that only the knock-out of ygbT increased in a linear manner depending on the culture period ( Supplementary Figure S6a , Supplementary Table S12 ). The change in fitness resulting from the knock-out of ygbT was confirmed by constructing and transforming cells with a single plasmid targeting ygbT (Supplementary Figure S6b) .
In summary, the CRISPR/retron system we developed efficiently generates programmed substitutions and enables the identification of mutants exhibiting phenotypes related to targeted chemical responses or enhanced proliferation. The feasibility of the method was demonstrated in an experiment using a genome-scale library, which identified ygbT as a gene involved in regulating the growth of E. coli, although the underlying mechanism remains to be elucidated. Our CRISPR/retron method relies on the abundance of msd sequences rather than the mutant allele frequency obtained by amplification of individual loci; therefore, our method is suitable for analyzing thousands of mutants.
It is generally difficult to extend the size of the library using the other method 18, 22 , which uses individually amplified genomic sequences, because it is difficult to identify a mutation.
The CRISPR/retron system described here provides enhanced editing efficiency of the bacterial genome compared with previous methods utilizing the retron system 13 ; however, a non-negligible proportion of unedited cells was still observed. Unedited cells can be problematic because their presence can interfere with interpretation when the screening process is not based on chemical selection. Enhancing the recombineering machinery via knock-out of exonucleases 14 , for example, could help reduce the proportion of unedited cells.
Although the use of our system is currently limited to bacterial engineering, we expect that it could be applied to a variety of other species by adapting their expression system, similar to the case of CRISPEY system. We anticipate that use of a lentivirus vector would yield similar results in mammalian cells, but this would require development of a chemical-or siRNA-mediated strategy to inhibit non-homologous end joining repair. We believe that integration of the above-mentioned improvements in our CRISPR/retron system would facilitate its use in the explorations of cancer-associated substitution variants, Mendelian-inherited disorders, and other phenotypes of interest in mammalian cells.
METHODS

Bacterial strains, antibiotics, induction, and electroporation
EcNR2 18 , EcHB3 ( Supplementary Table S6 IPTG was added to a final concentration of 1 mM. Electroporation was performed as follows: cells were grown until reaching an OD 600 of 0.7. Next, cells equivalent to 1 ml of culture medium were washed twice with 1 ml of ddH2O and resuspended in 50 μ l of the appropriate product. The cells were then pulsed with 1.8 kV in a 1-mm-gap cuvette (Bio-Rad, USA).
CRISPR/retron plasmid construction for targeting single genes
Oligonucleotides for constructing the msd and spacer inserts were designed and synthesized with the desired mutation sequences and one synonymous mutation in the protospacer adjacent motif (PAM) sequence in order to prevent killing of the engineered cells (IDT, USA) ( Supplementary Table S6 ).
The inserts were amplified as follows: 0.1 pmol of each template was diluted with ddH2O up to 8 E ach msd and spacer insert was cloned into EcoRI-and AflII-digested pRC_blank_01 or pRC_blank_02 vector by Gibson assembly. Information regarding the constructed plasmids and oligomer sequences is provided in Supplementary Tables S1, S2, and S6.
Preparation of the degenerate library
Oligonucleotides for the N6 experiment were synthesized at IDT ( Supplementary Table S6 ). The Table S6 ). The plasmid was purified using Ampure XP beads and subsequently transformed into C2566 by electroporation. Cells were recovered after culture in 3 ml of LB broth overnight at 37°C.
The recovered cells were added to 7 ml of LB medium and incubated overnight at 37°C. Plasmid DNA was then isolated from the transformants using an Exprep plasmid SV kit (GeneAll, Korea).
Preparation of the genome-scale library
Spacers and donor DNAs were designed based on the MG1655 reference genome (ASM584v2). All possible spacers with PAM (NGG/NAG) sequences within the gene were listed. Then, we chose spacers that contained targetable codons that could be changed to stop codons by replacing one or two bases (i.e., NAG, NGA, NAA, TNG, TGN). We then picked one spacer per gene for which the position was between residues corresponding to 30-70% of an open reading frame. The donor DNA was designed to replace the target codon with a stop codon and contain an altered PAM sequence to prevent recognition of the edited genome.
The sequence was designed as follows in order to reduce the oligonucleotide length: extension at 72°C for 1 min. The amplicons were then cloned into the pRC_blank_02 plasmid using transformed into C2566 via electroporation, and the plasmid library was extracted using a Qiagen plasmid maxi prep kit. The RT-beta sequence ( Supplementary Table S1 ) was inserted into this plasmid library via EcoRI linearization and Gibson assembly to generate the complete knock-out library. This step was performed in 12 parallel reactions.
Genome editing using the CRISPR/retron system
EcHB3 cells were sequentially electroporated with pN249 and pCas9_T7 to express T7 polymerase and Cas9, respectively, yielding ENC cells. The CRISPR/retron plasmid was then electroporated into the ENC cells, which were then transferred to LB broth without antibiotics for a 6-h recovery.
Transformants were transferred to LB broth containing appropriate selective antibiotics, incubated at 30°C, and diluted 1:100 with 10 ml of fresh LB broth every 12 h.
Deep sequencing for genome and msd region
Genomic and plasmid DNA were extracted from transformants using a DNeasy Blood & Tissue kit (Qiagen, Germany) and Exprep plasmid SV kit, respectively. Targeted loci and msd regions were amplified from a mixture of 200 ng of template, 10 pmol of each primer pair ( Supplementary Table   S6 ), and 10 μ l of KAPA HiFi HotStart Ready Mix. Reactions were carried out as follows: 95°C for 3 min, 25 cycles (20 cycles for msd) of 95°C for 30 s, 60°C for 30 s, and 72°C for 30 s, with final extension at 72°C for 1 min. In cases of more than one condition, the samples were amplified using barcoded primers and then pooled. The amplified products were prepared for NGS using a SPARK DNA Sample Prep kit (Enzymatics, USA). Sequencing was performed using an Illumina HiSeq 4000 or NextSeq 500 sequencer (data deposited in the SRA [PRJNA598315]). Raw data were demultiplexed by flanked barcodes; msd and targeted sequences were analyzed by comparison with the wild-type sequences.
Correlation coefficient calculation
To investigate the correlation between msd and variant depth, Pearson correlation coefficients were calculated, as follows. To normalize differences in the amount of data, we corrected for depth value by normalizing the total depth to 10 4 , and 1 was added to the ND to avoid a ND of <1. This approach, also used previously 3 , is represented by the following equation: 
